Enhesa GHS+ Chemical Hazard Assessment framework overview
Learn how we generate and maintain Chemical Hazard Assessments (CHAs)—including the process steps, data requirements, evaluation criteria, and assessor qualifications.
Table of Contents
-
- Step 1 – Confirm Chemical Identity
- Step 2 – Screen Against Chemical Lists
- Step 3 – Endpoint-Level Hazard Assessment
- Step 4 – Overall Chemical Hazard Categorization
- Step 5 – Quality Assurance & Verification
- Step 6 – Ongoing Maintenance
- References
- Appendix A: SciveraLENS GHS+ Chemical Hazard Assessment Framework – Criteria by Endpoint
Introduction
Since SciveraLENS was founded in 2008, our toxicologists have performed comprehensive chemical hazard assessments using procedures and criteria established by government authorities, accreditation bodies, and widely accepted toxicology practices.
This page outlines the steps, data requirements, evaluation criteria, and assessor qualifications used by the Enhesa Sustainable Chemistry team to generate and maintain a Chemical Hazard Assessment (CHA). These assessments evaluate the human and environmental health characteristics of industrial chemicals and are all available within our Chemical Assess and Supply Chain Connect offerings, which use our platform SciveraLENS(R).
Hazard Assessment Overview
Our toxicologists follow a structured process that:
-
Confirms the identity of the chemical under assessment
-
Screens the chemical against authoritative and regulatory lists to identify early indicators of potential concern
-
Assesses hazard characteristics across 24 human and environmental health endpoints, plus relevant physical hazard endpoints
-
Determines an overall hazard category for the chemical, integrating list reviews and endpoint assessment results
Figure 1-1: SciveraLENS GHS+ Chemical Hazard Assessment Process Flow Diagram
We’ve built and updated the GHS+ Chemical Hazard Assessment Process (“GHS+”) on a foundation of the broadly-accepted approach, endpoints, and criteria from the following leading documented references for best practices in this discipline:
Reference Foundations for GHS+
Enhesa GHS+ Chemical Hazard Assessment Process
Enhesa Sustainable Chemistry’s GHS+ process ensures a thorough and scientifically grounded Chemical Hazard Assessment (CHA). The steps below outline our standardized approach.
Step 1 – Confirm Chemical Identity
To begin a CHA, our toxicologists first verify the identity of the chemical using a set of accepted methods. This step ensures a reliable connection between the substance and its relevant data across physical-chemical, human health, and environmental endpoints.
Primary Identifier:
- CAS RN (Chemical Abstract Service Registry Number): The most widely used unique identifier, linking chemicals to data. While there are over 279 million CAS RNs, we focus on the ~400,000 relevant to consumer products and industrial applications in our SciveraLENS Chemical Data Repository.
Other Identifiers (if CAS RN is missing or conflicting):
- EC Number (ECHA)
- US EPA PMN (Pre-Manufacture Notification Number)
- SMILES notation (molecular structure)
- Other authoritative references
Accurate chemical identification ensures compatibility with regulatory lists, minimizes ambiguity from naming conventions, and supports the use of modeling tools and analog analysis.
Step 2 – Screen Against Chemical Lists
Next, we screen the chemical against a curated collection of 600+ lists within SciveraLENS, organized into:
- Regulatory Lists
- Authoritative Lists
- Restricted Substance Lists (RSLs)
- Screening Lists
- Watch Lists
- Preferred Lists
- Chemical Groups
- Informational/Inventory Lists
These lists help identify initial indications of concern for human or environmental health endpoints. List screening is not equivalent to a full hazard assessment. While helpful for early prioritization, only a full assessment can determine the true hazard profile.
Many lists flag groups of chemicals (e.g., “mercury and its compounds”) rather than individual substances. Our team maps group listings to specific chemicals—a complex but essential task to provide clarity for users.
View the full roster of 600+ lists available.
Step 3 – Endpoint-Level Hazard Assessment
Toxicologists assess each endpoint using multiple data types:
- Authoritative Lists
- Regulatory Lists
- Experimental Data
- Modeled Data
- Analogous Data
- Expert Judgment
Data Sources Include:
- NIH/NLM (e.g., PubChem)
- ECHA REACH dossiers
- US EPA databases
- NTP reports
- IARC monographs
- ToxPlanet
- Peer-reviewed literature
Modeling Tools:
- OECD QSAR Toolbox
- US EPA EpiSuite
- US EPA T.E.S.T.
- PBT Profiler (referenced but no longer supported)
Best Practices:
- Analog Read-Across: Used when direct data is missing.
- Expert Judgment: Toxicologists assess data quality and consistency.
- Data Reliability: High-quality experimental data is preferred. Klimisch scores and other indicators are used, but expert review is central.
- Weight-of-Evidence: When data conflict, we apply a precautionary principle, classifying at the highest supported hazard level.
Endpoints Assessed in the GHS+ Chemical Hazard Assessment
We evaluate three endpoint categories: Human Health, Environmental Health, and Physical-Chemical Properties. Each includes Core and Supplemental endpoints.
Human Health Endpoints
Core Endpoints
Required for an overall hazard category other than “Gray” (i.e., insufficient data):
- Carcinogenicity
- Mutagenicity / Genotoxicity
- Developmental Toxicity
- Reproductive Toxicity
- Endocrine Activity
Supplemental Endpoints
Contribute to the hazard profile; data gaps are permitted:
- Acute Oral Toxicity
- Acute Dermal Toxicity
- Acute Inhalation Toxicity
- Respiratory Sensitization
- Dermal Sensitization
- Dermal Irritation
- Eye Irritation
- Systemic Toxicity (Single and Repeat Dose)
- Neurotoxicity (Single and Repeat Dose)
- Sensory Irritation
- Aspiration Potential
To avoid a “Gray” score, all Core Human Health Endpoints must be conclusively assessed. Supplemental endpoints support the overall picture but are not all mandatory for a conclusive score.
Environmental Health Endpoints
Core Endpoints
Required for a conclusive overall environmental hazard category:
- Persistence
- Bioaccumulation
- Acute or Chronic Aquatic Toxicity
Supplemental Endpoint
- Mobility (assessed and documented; not factored into scoring)
Supplemental Physical-Chemical Endpoints
- Flammability
- Reactivity
- Environmental Transformation Products
If a transformation product is persistent, bio-accumulative, or toxic, it may affect the scoring of related endpoints like Persistence or Toxicity.
Hazard Communication: The GHS+ Traffic Light System
Each endpoint and overall hazard assessment is communicated using a color-coded system.
Table 2-1: SciveraLENS GHS+ Endpoint-Level Hazard Assessment Conditions
| Color Code | Hazard Level | Meaning |
|---|---|---|
| Low Hazard | Indicates a low hazard for the specific endpoint or overall chemical. | |
| Moderate Hazard | Indicates a moderate hazard. | |
| High Hazard | Indicates a high hazard. | |
| Very High Hazard | Indicates a very high hazard. | |
| Insufficient Data | Data are insufficient for assessment. | |
| Assessment in Progress | No concerns found during list screening; assessment not yet complete. | |
| Modeled/Analog Data | Indicates use of modeled, analogous, or expert judgment data in the score. |
Step 4 – Overall Chemical Hazard Categorization
While individual endpoint results provide detailed insight into hazard type and severity, an overall hazard category enables efficient comparison, prioritization, and alternatives assessment.
To assign this category, Enhesa Sustainable Chemistry uses a rules-based system implemented in SciveraLENS. The system evaluates all endpoint-level assessments to determine the Overall Hazard Category.
SciveraLENS Overall Chemical Hazard Categories and Rules
| Category | Criteria |
|---|---|
| – All endpoints show conclusive or limited-evidence low hazard – No data gaps for Core or Supplemental Endpoints |
|
| – All Human Health Core Endpoints are low hazard with no data gaps – One or more Supplemental Endpoints are moderate hazard – One Environmental Fate Endpoint may be high if others are low – No endpoints show very high hazard – No more than three Supplemental data gaps |
|
| – One or more Supplemental Endpoints are high or very high hazard – No Core Endpoints are high or very high hazard – No Environmental Fate Endpoints are high if paired with moderate Human Health or Ecotoxicity hazards – No more than three Supplemental data gaps – No Core data gaps |
|
| – One or more Human Health Core Endpoints are high or very high hazard, or – Two or more Environmental Health Core Endpoints are high or very high hazard (e.g., Persistence + Bioaccumulation), or – Very High Persistence or Bioaccumulation combined with very high acute or high chronic Human Health hazards |
|
| – One or more Core Endpoint data gaps, or – Four or more Supplemental Endpoint data gaps |
|
Step 5 – Quality Assurance & Verification
GHS+ hazard assessments are completed within our Chemical Data Repository (CDR), the engine behind SciveraLENS. Key QA features include:
-
Quantitative scoring integration for endpoints like acute and aquatic toxicity
-
Source tracking to document all reviewed references
-
Workflow stages based on endpoint types (e.g., CMRD, PBT) and status (Research → Assess → QA → Complete)
-
Dual review process: A board-certified toxicologist performs a full second review before finalizatio
Once verified, the hazard assessment is marked “Complete” and fully aligned with the GHS+ framework.
Enhesa Sustainable Chemistry continuously improves the GHS+ methodology ensuring the framework evolves with new science and stakeholder input.
Step 6 – Ongoing Maintenance
Hazard assessments are actively maintained through a structured, recurring update process:
-
List monitoring and updates propagate automatically across affected chemicals
-
New hazard data is evaluated and used to revise endpoint scores
-
User alerts notify SciveraLENS users of changes to chemicals of interest
References
-
US Environmental Protection Agency Design for Environment Program
Alternatives Assessment Criteria for Hazard Evaluation, Version 2.0 (2011) -
National Academy of Sciences
A Framework to Guide the Selection of Chemical Alternatives (2014) -
United Nations
Globally Harmonized System (GHS) of Classification and Labelling of Chemicals, 10th Revised Edition (2023) -
NSF International / Green Chemistry Institute / American National Standard
NSF/GCI/ANSI 355 – 2011: Greener Chemicals and Processes Information
(May require purchase or institutional access) -
Global Electronics Council & TÜV Rheinland
Criteria for the Sustainability Assessment of Network Equipment for the EPEAT® Ecolabel and TÜV Rheinland Green Product Mark (2021)
(Specific criteria documents are available via GEC’s EPEAT website or through partner certification bodies)
Appendix A: SciveraLENS GHS+ Chemical Hazard Assessment Framework – Criteria by Endpoint
Human Health Endpoints – Chronic
| Hazard | GHS+ Criteria | Very High | High | Moderate | Low |
| Carcinogenicity | GHS | GHS Category 1A – Known human carcinogen (largely based on human evidence) | GHS Category 1B – Presumed human carcinogen (largely based on animal evidence) | GHS Category 2 – Suspected human carcinogen | |
| GHS+ Qualitative Assessment of Available Data | Experimental and modeling data may be used. | Experimental and modeling data may be used. | Experimental and modeling data may be used. Modeling data may not be used alone. Negative modeling with negative Mutagenicity/Genotoxicity and repeated dose Systemic Toxicity. | ||
| Mutagenicity/Genotoxicity | GHS | GHS Category 1A | GHS Category 1B | GHS Category 2 | |
| Known to induce heritable mutations in germ cells of humans | Presumed to induce heritable mutations in germ cells of humans. Experimental and modeling data may be used. | Suspected of inducing heritable mutations in the germ cells of humans. Experimental and modeling data may be used. | Experimental and modeling data may be used. Modeling data may not be used alone. | ||
| Authoritative Lists | EU Category 1 | EU Category 2 | EU Category 3 | ||
| Developmental and Reproductive Toxicity (scored as separate endpoints) | GHS | GHS Category 1A | GHS Category 1B | GHS Category 2 | |
| Known human reproductive toxicant | Presumed human reproductive toxicant | Suspected human reproductive toxicant | |||
| Assessment of Available Quantitative Data (quantitative values are used for guidance only, considered in the context of maternal toxicity in relation with reproductive / developmental effects) | NOAEL/LOAEL oral (mg/kg/day): <50 | NOAEL/LOAEL oral (mg/kg/day): 50-250 | NOAEL/LOAEL oral (mg/kg/day): >250 | ||
| NOAEL/LOAEL dermal (mg/kg/day): <100 | NOAEL/LOAEL dermal (mg/kg/day): 100-500 | NOAEL/LOAEL dermal (mg/kg/day): >500 | |||
| NOAEL/LOAEL inhalation (vapor/gas) (mg/L/day): <1 | NOAEL/LOAEL inhalation (vapor/gas) (mg/L/day): 1-2.5 | NOAEL/LOAEL inhalation (vapor/gas) (mg/L/day): >2.5 | |||
| NOAEL/LOAEL inhalation (dust/mist/fume) (mg/L/day): <0.1 | NOAEL/LOAEL inhalation (dust/mist/fume) (mg/L/day): 0.1-0.5 | NOAEL/LOAEL inhalation (dust/mist/fume) (mg/L/day): >0.5 | |||
| Qualitative Assessment of Available Data | Experimental and modeling data may be used. | Experimental and modeling data may be used. | Experimental and modeling data may be used. Modeling data may not be used alone | ||
| Authoritative Lists | EU Category 1 | EU Category 2 | EU Category 3 | ||
| California Proposition 65 – listed | |||||
| Endocrine Activity | GHS+ Qualitative Assessment of Available Data | Evidence of endocrine disrupting activity in appropriate assays. Evidence or endocrine activity and related human health effect. SVHC endocrine chemicals. When C, D, R and TOST are H and in vivo effect is endocrine-related. | Evidence of endocrine activity. When D, R and/or TOST are M with in vivo endocrine-related effects (e.g., thymus, thyroid). Listed on relevant lists; indication of endocrine activity in studies (modeling and in vitro). Modeling indicates “active”. | No evidence of activity (no binding, perturbation, or evidence of endocrine-related adverse effects) in appropriate assays and no structural alerts. Need negative data (modeled, in vitro, and in vivo) for key EATS (estrogenic, androgenic, thyroid, steroidogenic) endocrine pathways. | |
| Authoritative Lists | EU Category 1 | EU Category 2 | |||
| Hazard Lists | ChemSec SIN Listed | TEDX Listed |
Human Health Endpoints – Acute
| Hazard | GHS+ Criteria | Very High | High | Moderate | Low |
| Acute Oral Toxicity (LD50, rat) | GHS | GHS Category 1 or 2 | GHS Category 3 | GHS Category 4 | GHS Category 5 or “not classified” |
| Qualitative Assessment of Available Data (Experimental or modeled) | LD50 ≤ 50 mg/kg | 50 mg/kg< LD50 ≤ 300 mg/kg | 300 mg/kg < LD50 ≤ 2000 mg/kg | LD50 > 2000 mg/kg | |
| Acute Dermal Toxicity (LD50, rabbit) | GHS | GHS Category 1 and 2 | GHS Category 3 | GHS Category 4 | GHS Category 5 or “not classified” |
| Qualitative Assessment of Available Data. | LD50 ≤ 200 mg/kg | 200 mg/kg < LD50 ≤ 1000 mg/kg | 1000 mg/kg < LD50 ≤ 2000 mg/kg | LD50 > 2000 mg/kg | |
| Acute Inhalation Toxicity (LC50, rat) | GHS | GHS Category 1 and 2 | GHS Category 3 | GHS Category 4 | GHS Category 5 or “not classified” |
| Qualitative Assessment of Available Data. | Vapor – < 2 mg/L; Dust/mist - LC50 ≤ 0.5 mg/L | Vapor- 2 mg/L < LC50 ≤ 10mg/L; Dust/mist - 0.5 mg/L < LC50 ≤ 1.0 mg/L | Vapor -10 mg/L < LC50 ≤ 20mg/L; Dust/mist - 1 mg/L < LC50 ≤ 5mg/L | Vapor – LC50 > 20 mg/L; Dust/mist LC50 > 5mg/L | |
| Dermal Irritation | GHS | GHS Category 1, 1A, B and C | 2-Irritant | 3-Mild irritant | “Not Classified” |
| Qualitative Assessment of Available Data including Modeling Results (e.g., Toxtree “me” data cards) | 1A – Evidence of irreversible damage to skin in human following exp of up to 3 min and up to 1 hr observation; or in animal experience or test data; pH extremes of ≤ 2 and ≥ 11.5. 1B,C-Evidence of irreversible damage to skin in human following exp of > 3 min and up to 4 hrs and observations of up to 14 days, or in animal experience or test data; pH extremes of ≤ 2 and ≥ 11.5 — NOTE: If only GHS Category 1 is specified (but not 1A or 1B or 1C) then descriptive data of the hazard will be used to determine score. | Evidence of reversible damage to skin following exp of up to 4 hrs (human experience or data or animal experience or data). Modeling data may be used. | Evidence of reversible damage to skin following exp of up to 4 hrs in animal experience or test data. Modeling data may be used. | Adequate data available, and negative studies, no structural alerts, GHS not classified. Modeling data may not be used alone. | |
| Acute Eye Irritation | GHS | GHS Category 1 | GHS Category 2A | GHS Category 2B | |
| Qualitative Assessment of Available Data | Damage to the eye which is not fully reversible within 21 days (human data/experience) or positive animal experience or test data in at least 1 animal | Changes in the eye which are fully reversible within 21 days (human data/experience) or positive animal experience or test data in at least 2 animals — NOTE: If only GHS Category 2 is specified (but not 2A or 2B) then descriptive data of the hazard will be used to determine score. Modeling data may be used. | Evidence of mild eye irritation in human experience or data or animal experience or test data indicating complete reversibility of lesions within 7 d — NOTE: If only GHS Category 2 is specified (but not 2A or 2B) then descriptive data of the hazard will be | Adequate data available, and negative studies, no structural alerts, GHS not classified. Modeling data may not be used alone. | |
| Sensory Irritation | GHS+ Qualitative Assessment of Available Data | RD50 ≤ 5 ppm | 5 ppm < RD50 ≤ 1500 ppm | RD50 > 1500 ppm | |
| GHS STOT H335 |
Human Health Endpoints – Other
| Hazard | GHS+ Criteria | Very High | High | Moderate | Low |
| TOST – Single Exposure (Specific target organ systemic toxicity following single exposure) | GHS | GHS Category 1 | GHS Category 2 | GHS Category 3 | GHS Category “Not Classified” |
| Qualitative Assessment of Available Data | Reliable evidence of a significant adverse effect on specific organ/systems or systemic toxicity in humans or animals. Oral ≤ 300mg/kg; Dermal ≤ 1000 mg/kg; Inhalation -vapor/gas – ≤ 10 mg/L/4hr; dust/mist/fumes – ≤ 1.0mg/L/4hr | Evidence of a harmful adverse effect on specific organ/systems or systemic toxicity from animal studies or humans. Oral – > 300 to ≤ 2000mg/kg; Dermal – > 1000 to ≤ 2000 mg/kg; Inhalation -vapor/gas – > 10 to ≤ 20mg/L/4hr; dust/mist/fume – > 1.0 to ≤ 5.0mg/L/4hr | Evidence of transient (1) irritant effects on respiratory tract in humans or (2) transient narcotic effects from animal studies and in humans | Adequate data available, and negative studies, no structural alerts, GHS not classified | |
| TOST – Repeat Exposure (Specific target organ systemic toxicity following repeated exposure; based on 90 day exposures) | GHS | GHS Category 1 | GHS Category 2 | Not Classified | |
| NOAEL/LOAEL oral (mg/kg/day): <10 | NOAEL/LOAEL oral (mg/kg/day): 10-100 | NOAEL/LOAEL oral (mg/kg/day): >100 | |||
| NOAEL/LOAEL dermal (mg/kg/day): <20 | NOAEL/LOAEL dermal (mg/kg/day): 20-200 | NOAEL/LOAEL dermal (mg/kg/day): >200 | |||
| NOAEL/LOAEL inhalation (vapor/gas) (mg/L/6h/day): <0.2 | NOAEL/LOAEL inhalation (vapor/gas) (mg/L/6h/day): 0.2-1.0 | NOAEL/LOAEL inhalation (vapor/gas) (mg/L/6h/day): >1.0 | |||
| NOAEL/LOAEL inhalation (dust/mist/fume) (mg/L/6h/day): <0.02 | NOAEL/LOAEL inhalation (dust/mist/fume) (mg/L/6h/day): 0.02-0.2 | NOAEL/LOAEL inhalation (dust/mist/fume) (mg/L/6h/day): >0.2 | |||
| Qualitative Assessment of Available Data including Modeling Alerts as needed | Reliable evidence of a significant adverse effect on specific organ/systems or systemic toxicity in humans or animals | Evidence of a harmful adverse effect on specific organ/systems or systemic toxicity from animal studies or humans. | Adequate data available, and negative studies, no structural alerts, GHS not classified. Modeling data may not be used alone. | ||
| Aspiration Hazard | GHS | GHS Category 1 | GHS Category 2 | ||
| Qualitative Assessment of Available Data | Human evidence; hydrocarbons with kinematic viscosity of 20.5 mm2/s or less, measured at 40° C | Based on animal studies; kinematic viscosity of 14 mm2/s or less, measured at 40°C | |||
| Dermal Sensitization | GHS | GHS Category 1A | GHS Category 1B | ||
| Substances showing a high frequency of occurrence in humans and/or a high potency in animals | Substances showing a low to moderate frequency of occurrence in humans and/or a low to moderate potency in animals | ||||
| Hazard Lists | MAK Sensitizing Substances Sh (Skin) or Sah (Respiratory and Skin) | ||||
| Qualitative Assessment of Available Data | Positive responses in predictive Human Repeat Insult Patch Tests (HRIPT) or other human experience or analogy to chemical classes and/or positive, animal or LLNA data. Modeling data may be used. | Modeling data may be used. | Adequate data available, and negative studies, no structural alerts, GHS not classified. Modeling data may not be used alone. | ||
| Respiratory Sensitization | GHS | GHS Category 1A | GHS Category 1B – Low to moderate sensitization rate in humans or probability thereof based upon animal or other tests | ||
| High sensitization rate in humans or probability thereof based upon animal or other tests | |||||
| Hazard Lists | MAK Sensitizing Substances Sa (Respiratory) or Sah (Respiratory and Skin) | AOEC | |||
| Neurotoxicity | See TOST, Single and Repeat | see TOST | see TOST | see TOST | |
| Hazard Lists | Listed on Grandjean & Landrigan (ME) | ||||
| Qualitative Assessment of Available Data | Evidence of neurotoxicity in humans or positive results in appropriate animal tests assessing functional observational battery, motor activity, neuropathology | Probable human neurotoxicant (some positive results in appropriate animal tests) | No evidence for a neurotoxic hazard |
Ecotox and E-Fate Endpoints
| Hazard | GHS+ Criteria | Very High | High | Moderate | Low |
| Eco Toxicity | |||||
| Acute Hazards to the Aquatic Environment | GHS | GHS Category 1 | GHS Category 2 | GHS Category 3 | GHS Category “Not Classified” |
| Qualitative Assessment of Available Data (modeling data may be used) | LC/EC50 ≤ 1mg/L (fish 96hr LC50, crustacea 48hr EC/LC50, or aquatic plant 72 or 96hr ErC50). | 1 mg/L < LC/EC50 ≤ 10 mg/L (fish 96hr LC50, crustacea 48hr EC/LC50, or aquatic plant 72 or 96hr ErC50) | 10 mg/L < LC/EC50 ≤ 100 mg/L (fish 96hr LC50, crustacea 48hr EC/LC50, or aquatic plant 72 or 96hr ErC50) | LC/EC50 > 100mg/L | |
| Chronic Hazards to the Aquatic Environment | GHS | GHS Category 1 | GHS Category 2 | GHS Category 3 and 4 | GHS Category “Not Classified” |
| Qualitative Assessment of Available Data (modeling data may be used) | LC/EC50 ≤ 0.1 mg/L | LC/EC50 > 0.1 to ≤ 1mg/L (fish 96hr LC50, crustacea 48hr EC/LC50, or aquatic plant 72 or 96hr ErC50) and BCF ≥ 500 or if absent log Kow ≥ 4 | > 1 mg/L 1mg/L. Category 4 – Poorly soluble and no acute toxicity is observed upon water solubility and BCF≥ 500 or if absent log Kow ≥ 4, unless chronic NOECs > 1mg/L | LC/EC50 >10 mg/L | |
| Environmental Fate | |||||
| Persistence | Qualitative Assessment of Available Data | ||||
| % Biodegradation in 28 days | ≤10% in 28 days, or when less than 30% in >28 days | greater than 10% to <30% in 28 days | ≥30% to 70% in 28 days | Rapidly degradable; Degradation >70% of dissolved organic carbon in 28 days (reached within a 10-day window); if not available BOD (5 days)/ COD ratio ≥0.5, considered indicative of rapid degradation | |
| Biological Oxygen Demand (BOD)/Chemical Oxygen Demand (COD) ratio | BOD (5 day)/COD ratio <0.2, not biodegradable | BOD (5 day)/COD ratio 0.2-0.4, slowly biodegradable | BOD (5 day)/COD ratio >0.4-0.5, moderately biodegradable | BOD (5 day)/COD ratio >0.5, easily biodegradable | |
| t 1/2 in days | Persistence in soil or sediment: Half-life>180 days or recalcitrant; Persistence in water: Half-life>60 days or recalcitrant; Persistence in air: >5 days or recalcitrant | Soil or Sediment: >60 to 180 days; Water: >40 to 60 days; Air 2 to 5 days | Soil or Sediment: 16 to 60 days; Water: 16 to 40 days; Air: Half-life assessed as high or low | Soil, Sediment, or Water<16 days; Air<2 days; GHS "Rapid degradability"; Meets 10-day "Ready Biodegradability" | |
| Chemical Class | Inorganic – Determined by compound characteristics under environmental conditions | ||||
| Potential for Long-range Transport | Evidence | Suggestive Evidence | |||
| Potential for Actual Bioaccumulation | Qualitative Assessment of Available Data (modeling data may be used) | BCF or BAF >5000 or log Kow >5 | BCF or BAF >1000 to 5000 or log Kow 4.5-5 | BCF or BAF 500 to 1000 or log Kow 4-4.5 | BCF or BAF >100 – 500 or log Kow <4.5 |
| Environmental Transformation Products (ETPs) | |||||
| Environmental Transformation Products (ETPs) | Qualitative Assessment of Available Data (modeling data may be used) | Experimental data indicating persistent and very highly toxic degradation products. | Experimental or modeling data indicating persistent and highly toxic degradation products. | Experimental or modeling data indicating persistent and moderately toxic degradation products. | Data are available suggesting low concern for ETPs (e.g., low persistence, low toxicity). |
| Mobility | |||||
| Mobility | Qualitative Assessment of Available Data (modeling data may be used) | Log Koc < 2.0 | 2.0 < Log Koc < 3.0 | Log Ko > 3.0 | |
Physical Hazard Endpoints
| Hazard | GHS+ Criteria | Very High | High | Moderate | Low |
| Flammability | GHS: Flammable Liquids | GHS Category 1 | GHS Category 2 | GHS Category 3 and 4 | GHS Category “Not Classified” |
| GHS: Flammable Gases | GHS Category 1 | GHS Category 2 or GHS Category A | GHS Category B or GHS Category “Not Classified” | ||
| GHS: Flammable Solids | GHS Category 1 | GHS Category 1 | GHS Category 2 | GHS Category 3 or GHS Category “Not Classified” | |
| GHS: Aerosols | LC/EC50 ≤ 0.1 mg/L | GHS Category 1 | GHS Category 2 | GHS Category 3 or GHS Category “Not Classified” | |
| GHS: Pyrophoric Liquids | GHS Category 1 | GHS Category “Not Classified” | |||
| GHS: Pyrophoric Solids | GHS Category 1 | GHS Category “Not Classified” | |||
| Qualitative Assessment of Available Data (modeling data may be used) | Flashpoint: flammable liquids | Flash point < 23 ∘C and initial boiling point ≤ 35 ∘C | Flash point < 23 ∘C and initial boiling point > 35 ∘C | Flash point ≥ 23 ∘C and ≤ 93 ∘C | Flash point > 93 ∘C |
| Reactivity | GHS: Explosives | GHS Unstable | GHS Division 1.1, 1.2, or 1.3 | GHS Division 1.4 or 1.5 | GHS Division 1.6 or GHS Category “Not Classified” |
| GHS: Self-reactive Substances | GHS Type A or B | GHS Type C or D | GHS Type E or F | GHS Type G or GHS Category “Not Classified” | |
| GHS: Substances which on contact with water emit flammable gases | GHS Category 1 | GHS Category 2 | GHS Category 3 | GHS Category “Not Classified” | |
| GHS: Oxidizing Gases | GHS Type A or B | GHS Type C or D | GHS Type E or F | GHS Type G or GHS Category “Not Classified” | |
| GHS: Oxidizing Liquids and Solids | GHS Category 1 | GHS Category 2 | GHS Category 3 | GHS Category “Not Classified” | |
| GHS: Organic Peroxides | GHS Type A or B | GHS Type C or D | GHS Type E or F | GHS Type G or GHS Category “Not Classified” | |
| GHS: Self-Heating Substances | Experimental data indicating persistent and very highly toxic degradation products. | GHS Category 1 | GHS Category 2 | GHS Category “Not Classified” | |
| GHS: Substances Corrosive to Metal | GHS Category 1 | GHS Category “Not Classified” |
